BGMS Bio Green Med Solution, Inc.
Healthcare$0.96-0.52%ClosedMarket Cap: $2.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.78
P/S
1.39
EV/EBITDA
0.34
DCF Value
$5.02
FCF Yield
-85.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.3%
Operating Margin
-238.5%
Net Margin
-204.2%
ROE
-51.2%
ROA
-41.2%
ROIC
-53.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $778.0K | 18.3% | $-246.0K | $-197.0K | $— | — |
| Q4 null | $666.0K | 18.2% | $-1.1M | $-611.0K | $— | — |
| FY null | $747.0K | 18.5% | $-8.4M | $-3.0M | $— | — |
| Q3 null | $81.0K | 21.0% | $-992.0K | $-988.0K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.3M | $-1.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.0M | $-81.0K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-1.8M | $-3.1M | $— | — |
| FY null | $43.0K | 100.0% | $-12.0M | $-11.2M | $— | — |
| Q3 null | $10.0K | 100.0% | $-2.2M | $-2.0M | $— | — |
| Q2 null | $4.0K | 100.0% | $-3.6M | $-3.3M | $— | — |
| Q1 null | $29.0K | 93.1% | $-7.3M | $-2.9M | $— | — |
| Q4 2023 | $31.0K | 74.2% | $-5.8M | $-5.3M | $-1,495.31 | — |